Bank of America related stories
All articles and analysis
Report: BC Partners bring in bankers for FoxtonsFoxtons, the UK estate agency owned by global buyout group BC Partners, is having a tough time amid the housing market slowdown. Investment bankers from NM Rothschild are reportedly being asked to advise on a refinancing of the company’s £250m debt package.
- Conversus taps liquidity provider
The quoted fund of funds, backed by Bank of America and Oak Hill, has engaged ABN AMRO to issue a continuous quote on its shares. It is the second time the bank has provided the Euronext-traded fund with liquidity.
- Lehman Euronext fund becomes latest to seek liquidity
Lehman Brothers Private Equity Partners has reached an agreement with ABN AMRO to repurchase stock on its behalf, just a week after Euronext-quoted Conversus struck a similar deal.
- Publicis acquires Kekst and Co.
All of Kekst’s private equity clients, which include KKR, General Atlantic and Warburg Pincus, will stay with the firm.
- Bear Stearns Merchant Banking to spin off
The private equity arm of the fallen investment bank is ‘working aggressively’ to set up independent operations.
- Starwood launches infrastructure finance group
Former Bank of America executives will help the real estate investment firm's newly launched division to target investments in public infrastructure bonds.
- Blackstone to buy home healthcare provider for $1.6bn
Apria Healthcare Group has also secured a $280m credit facility in conjunction with the take-private, a positive sign for the leveraged buyout world as healthcare continues to be a favored target.
- Blackstone nabs SAC trading ace for Asian expansion
The firm has hired Aaron Nieman to build an event-driven hedge fund platform targeting the Asia-Pacific region.
- Good Energies recruits Benchmark Europe co-founder
The energy investment firm has continued its rapid growth by recruiting George Coelho, a venture capital veteran. Good Energies has an approximate €3bn holding in Q-Cells, a solar energy company.
- TPG to pay $1.3bn for Canadian drug firm(4)
Axcan Pharma has agreed to be taken private by TPG in a transaction valued at $1.3 billion. It’s the firm’s third healthcare acquisition this year.